Breaking News: Black Diamond Therapeutics Successfully Prices Public Offering of Common Stock
Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock CAMBRIDGE, Mass and NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with genetically defined cancers, today announced the pricing of an underwritten public…